These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 26409291)

  • 1. Prevention of recurrent pterygium with topical bevacizumab 0.05% eye drops: a randomized controlled trial.
    Kasetsuwan N; Reinprayoon U; Satitpitakul V
    Clin Ther; 2015 Oct; 37(10):2347-51. PubMed ID: 26409291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of different concentrations of topical bevacizumab on the recurrence rate of excised primary pterygium: a short-term follow-up study.
    Motarjemizadeh Q; Aidenloo NS; Sepehri S
    Int Ophthalmol; 2016 Feb; 36(1):63-71. PubMed ID: 25943172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparative Study of Topical Mitomycin C, Cyclosporine, and Bevacizumab after Primary Pterygium Surgery.
    Hwang S; Choi S
    Korean J Ophthalmol; 2015 Dec; 29(6):375-81. PubMed ID: 26635453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical application of bevacizumab as an adjunct to recurrent pterygium surgery.
    Ozgurhan EB; Agca A; Kara N; Yuksel K; Demircan A; Demirok A
    Cornea; 2013 Jun; 32(6):835-8. PubMed ID: 23187164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, controlled trial of conjunctival autografting combined with subconjunctival bevacizumab for primary pterygium treatment: 1-year follow-up.
    Nava-Castañeda A; Olvera-Morales O; Ramos-Castellon C; Garnica-Hayashi L; Garfias Y
    Clin Exp Ophthalmol; 2014 Apr; 42(3):235-41. PubMed ID: 23777441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subconjunctival bevacizumab immediately after excision of primary pterygium: the first clinical trial.
    Shenasi A; Mousavi F; Shoa-Ahari S; Rahimi-Ardabili B; Fouladi RF
    Cornea; 2011 Nov; 30(11):1219-22. PubMed ID: 21955635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of topical bevacizumab for inhibiting growth of impending recurrent pterygium.
    Fallah MR; Khosravi K; Hashemian MN; Beheshtnezhad AH; Rajabi MT; Gohari M
    Curr Eye Res; 2010 Jan; 35(1):17-22. PubMed ID: 20021250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical bevacizumab eyedrops for limbal-conjunctival neovascularization in impending recurrent pterygium.
    Wu PC; Kuo HK; Tai MH; Shin SJ
    Cornea; 2009 Jan; 28(1):103-4. PubMed ID: 19092418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial comparing mitomycin C and conjunctival autograft after excision of primary pterygium.
    Chen PP; Ariyasu RG; Kaza V; LaBree LD; McDonnell PJ
    Am J Ophthalmol; 1995 Aug; 120(2):151-60. PubMed ID: 7639298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiangiogenic therapy for pterygium recurrence].
    Leippi S; Grehn F; Geerling G
    Ophthalmologe; 2009 May; 106(5):413-9. PubMed ID: 19418056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized controlled prospective study to assess the role of subconjunctival bevacizumab in primary pterygium surgery in Indian patients.
    Singh P; Sarkar L; Sethi HS; Gupta VS
    Indian J Ophthalmol; 2015 Oct; 63(10):779-84. PubMed ID: 26655003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of different doses of subconjunctival bevacizumab on the recurrence rate of excised primary pterygium.
    Razeghinejad R; Banifatemi M; Hosseini H
    Bull Soc Belge Ophtalmol; 2013; (322):13-20. PubMed ID: 24923077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled trial of subconjunctival bevacizumab injection in impending recurrent pterygium: a pilot study.
    Lekhanont K; Patarakittam T; Thongphiew P; Suwan-apichon O; Hanutsaha P
    Cornea; 2012 Feb; 31(2):155-61. PubMed ID: 22081150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon Alpha-2b Eye Drops Prevent Recurrence of Pterygium After the Bare Sclera Technique: A Single-Center, Sequential, and Controlled Study.
    Yin M; Li H; Zhang Y; Dai H; Luo F; Pan Z
    Cornea; 2019 Oct; 38(10):1239-1244. PubMed ID: 31299663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary results of subconjunctival bevacizumab in primary pterygium excision.
    Razeghinejad MR; Hosseini H; Ahmadi F; Rahat F; Eghbal H
    Ophthalmic Res; 2010; 43(3):134-8. PubMed ID: 19887878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial of pterygium surgery with mitomycin C application using conjunctival autograft versus conjunctival-limbal autograft.
    Kheirkhah A; Hashemi H; Adelpour M; Nikdel M; Rajabi MB; Behrouz MJ
    Ophthalmology; 2012 Feb; 119(2):227-32. PubMed ID: 22153864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bevacizumab and ocular wound healing after primary pterygium excision.
    Banifatemi M; Razeghinejad MR; Hosseini H; Gholampour A
    J Ocul Pharmacol Ther; 2011 Feb; 27(1):17-21. PubMed ID: 20977367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated bevacizumab injections versus mitomycin C in rotational conjunctival flap for prevention of pterygium recurrence.
    Ozsutcu M; Ayintap E; Akkan JC; Koytak A; Aras C
    Indian J Ophthalmol; 2014 Apr; 62(4):407-11. PubMed ID: 24178405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of pterygium by ligation and bevacizumab injection.
    Nakasato H; Uemoto R; Mizuki N
    Cornea; 2012 Nov; 31(11):1339-41. PubMed ID: 22710493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subconjunctival bevacizumab injection for corneal neovascularization in recurrent pterygium.
    Bahar I; Kaiserman I; McAllum P; Rootman D; Slomovic A
    Curr Eye Res; 2008 Jan; 33(1):23-8. PubMed ID: 18214740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.